- Home
- FENG vs NXL Comparison
FENG vs NXL Comparison
Compare FENG & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENG
- NXL
- Stock Information
- Founded
- FENG 1998
- NXL 2010
- Country
- FENG China
- NXL United States
- Employees
- FENG N/A
- NXL N/A
- Industry
- FENG Broadcasting
- NXL Medical Specialities
- Sector
- FENG Industrials
- NXL Health Care
- Exchange
- FENG Nasdaq
- NXL Nasdaq
- Market Cap
- FENG 29.7M
- NXL 31.1M
- IPO Year
- FENG 2011
- NXL 2022
- Fundamental
- Price
- FENG $2.25
- NXL $2.01
- Analyst Decision
- FENG
- NXL Strong Buy
- Analyst Count
- FENG 0
- NXL 1
- Target Price
- FENG N/A
- NXL $5.00
- AVG Volume (30 Days)
- FENG 6.3K
- NXL 110.3K
- Earning Date
- FENG 03-11-2025
- NXL 03-14-2025
- Dividend Yield
- FENG N/A
- NXL N/A
- EPS Growth
- FENG N/A
- NXL N/A
- EPS
- FENG N/A
- NXL N/A
- Revenue
- FENG $96,408,461.00
- NXL $168,721.00
- Revenue This Year
- FENG N/A
- NXL $79.59
- Revenue Next Year
- FENG N/A
- NXL $334.65
- P/E Ratio
- FENG N/A
- NXL N/A
- Revenue Growth
- FENG 1.69
- NXL 52.35
- 52 Week Low
- FENG $1.67
- NXL $0.53
- 52 Week High
- FENG $4.15
- NXL $4.49
- Technical
- Relative Strength Index (RSI)
- FENG 47.35
- NXL 40.46
- Support Level
- FENG $2.10
- NXL $1.82
- Resistance Level
- FENG $2.33
- NXL $2.57
- Average True Range (ATR)
- FENG 0.11
- NXL 0.22
- MACD
- FENG -0.00
- NXL -0.01
- Stochastic Oscillator
- FENG 50.11
- NXL 25.33
About FENG Phoenix New Media Limited
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.